A record of what this supplier publishes about itself. It does not evaluate product quality, purity, sterility or suitability for any use, and it is not a recommendation.
A generated trace, not a reproduction of any document this supplier publishes. It is drawn solid because this entry links a certificate we opened and read; the accent band sits under the main peak, which is where a purity percentage comes from.
Products labelled for research use are not approved for personal, medical or veterinary use. This entry does not evaluate suitability for human consumption.
Looking for peptide treatment? Find a licensed clinic instead →FDA states the site offered "Semaglutide" and "Retatrutide" as unapproved new drugs, and that despite labelling products as "research chemicals only," website evidence established they were intended as drugs for human use. FDA requested a response; no evidence of resolution has been published.
Read the official FDA warning letter →Documentation is strong and unusually verifiable — 44 dated reports, batch-specific, each carrying a key the reader can check against the issuing laboratory. Two things pull the score down and neither concerns product quality: a US street address could not be verified from the site, and an FDA warning letter dated 2024-12-10 is on record for this entity and domain with no disclosure of it anywhere on the site.
The same categories are recorded for every supplier. Where evidence could not be obtained, the entry says so rather than inferring anything from the absence.
Could not verify a US street address: the About page states only "Based in USA" and the contact page returned HTTP 403. Support email and phone are published. FDA’s 2024 warning letter addressed the firm at a New York address.
44 dated test reports published and filterable; report examined is batch-specific (batch ED9319, analysis 2026-06-25) and carries a verification key checkable at the laboratory’s own site.
Janoshik Analytical named as issuer, with a customer-verifiable unique key per report. No accreditation number stated on the report examined.
Quality page states HPLC, LC-MS, NMR or equivalent. The report examined prints the purity result but not the method name; the file name indicates HPLC.
Site-wide footer disclaimer that products are for laboratory research use only and not for human consumption.
Detailed but restrictive: peptides cannot be returned at all; other categories 7 business days, unopened; refunds carry a 15% restocking fee per item plus a $25 processing fee.
An FDA warning letter dated 2024-12-10 is on record for this entity and its domain. No disclosure of it was found anywhere on the site.
We did not purchase, receive or test any product, and we do not rank suppliers against each other. A supplier-hosted certificate is evidence that a document was published — not evidence that a shipped unit matches it. HPLC area percent is chromatographic purity, not net peptide content, and no purity figure establishes sterility, correct labelling or human safety.